LncRNA GAS6-AS2 has been shown to act as an oncogene to promote the development of a number of tumors, such as hepatocellular carcinoma [10], breast cancer [11], osteosarcoma [12], non-small-cell lung cancer [9], bladder cancer [13], and melanoma [14]. This evidence concerns the gene GAS6 and osteosarcoma.